Tag | Content |
---|---|
UniProt Accession | HDAC5_HUMAN; Q9UQL6; |
Entrez ID | 10014 |
GenBank Protein ID | NM_001015053.1; NM_005474.4; XM_005256906.4; |
GenBank Nucleotide ID | NP_001015053.1; NP_005465.2; XP_005256963.1; |
Protein Name | Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9) |
Gene Name | HDAC5; KIAA0600 |
Organism | Homo sapiens |
NCBI Taxa ID | 9606 |
Functional Description | Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation by repressing transcription of myocyte enhancer MEF2C. During muscle differentiation, it shuttles into the cytoplasm, allowing the expression of myocyte enhancer factors. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. |
Sequence (Fasta) | MNSPNESDGM SGREPSLEIL PRTSLHSIPV TVEVKPVLPR AMPSSMGGGG GGSPSPVELR 60 GALVGSVDPT LREQQLQQEL LALKQQQQLQ KQLLFAEFQK QHDHLTRQHE VQLQKHLKQQ 120 QEMLAAKQQQ EMLAAKRQQE LEQQRQREQQ RQEELEKQRL EQQLLILRNK EKSKESAIAS 180 TEVKLRLQEF LLSKSKEPTP GGLNHSLPQH PKCWGAHHAS LDQSSPPQSG PPGTPPSYKL 240 PLPGPYDSRD DFPLRKTASE PNLKVRSRLK QKVAERRSSP LLRRKDGTVI STFKKRAVEI 300 TGAGPGASSV CNSAPGSGPS SPNSSHSTIA ENGFTGSVPN IPTEMLPQHR ALPLDSSPNQ 360 FSLYTSPSLP NISLGLQATV TVTNSHLTAS PKLSTQQEAE RQALQSLRQG GTLTGKFMST 420 SSIPGCLLGV ALEGDGSPHG HASLLQHVLL LEQARQQSTL IAVPLHGQSP LVTGERVATS 480 MRTVGKLPRH RPLSRTQSSP LPQSPQALQQ LVMQQQHQQF LEKQKQQQLQ LGKILTKTGE 540 LPRQPTTHPE ETEEELTEQQ EVLLGEGALT MPREGSTESE STQEDLEEED EEDDGEEEED 600 CIQVKDEEGE SGAEEGPDLE EPGAGYKKLF SDAQPLQPLQ VYQAPLSLAT VPHQALGRTQ 660 SSPAAPGGMK SPPDQPVKHL FTTGVVYDTF MLKHQCMCGN THVHPEHAGR IQSIWSRLQE 720 TGLLSKCERI RGRKATLDEI QTVHSEYHTL LYGTSPLNRQ KLDSKKLLGP ISQKMYAVLP 780 CGGIGVDSDT VWNEMHSSSA VRMAVGCLLE LAFKVAAGEL KNGFAIIRPP GHHAEESTAM 840 GFCFFNSVAI TAKLLQQKLN VGKVLIVDWD IHHGNGTQQA FYNDPSVLYI SLHRYDNGNF 900 FPGSGAPEEV GGGPGVGYNV NVAWTGGVDP PIGDVEYLTA FRTVVMPIAH EFSPDVVLVS 960 AGFDAVEGHL SPLGGYSVTA RCFGHLTRQL MTLAGGRVVL ALEGGHDLTA ICDASEACVS 1020 ALLSVELQPL DEAVLQQKPN INAVATLEKV IEIQSKHWSC VQKFAAGLGR SLREAQAGET 1080 EEAETVSAMA LLSVGAEQAQ AAAAREHSPR PAEEPMEQEP AL 1123 |
|
Database | Annotation |
---|---|
CTD (Curated) (count: 3) | MESH:D000275
; Adjustment Disorders MESH:D019970 ; Cocaine-Related Disorders MESH:D065627 ; Familial Primary Pulmonary Hypertension |
DisGeNet (Curated) (count: 7) (view all) | C0001546; Adjustment Disorders
C0011570; Mental Depression C0011581; Depressive disorder C0041696; Unipolar Depression C0236736; Cocaine-Related Disorders C0340543; Familial primary pulmonary hypertension |
GWASdb (count: 5) | rs228768; Multiple complex diseases; Null
rs228769; Bone mineral density (hip); bone resorption disease rs228769; Bone mineral density (spine); bone resorption disease rs453789; Triglycerides; coronary artery disease|lipid metabolism disorder|arteriosclerosis rs79605584; Cocaine dependence; cocaine dependence |
PTM | Modification Sites |
---|---|
Phosphorylation (count: 34) (view all) | 1071 FAAGLGRSLREAQAG dbPAF
1108 AAAAREHSPRPAEEP dbPAF 180 SKESAIASTEVKLRL dbPAF 181 KESAIASTEVKLRLQ dbPAF 206 TPGGLNHSLPQHPKC dbPAF 234 PQSGPPGTPPSYKLP dbPAF |
Acetylation (count: 1) | 533 QQQLQLGKILTKTGE PLMD |
Sumoylation (count: 2) | 35 IPVTVEVKPVLPRAM PLMD
533 QQQLQLGKILTKTGE PLMD |
Glycation (count: 2) | 194 LQEFLLSKSKEPTPG PLMD
196 EFLLSKSKEPTPGGL PLMD |
Network | Interaction | ||
---|---|---|---|
A | B | Source | |